99 related articles for article (PubMed ID: 30517243)
1. Relevance of hMLH1 -93G>A, 655A>G and 1151T>A polymorphisms with colorectal cancer susceptibility: a meta-analysis based on 38 case-control studies.
Zare M; Jafari-Nedooshan J; Jafari M; Neamatzadeh H; Abolbaghaei SM; Foroughi E; Nasiri R; Zare-Shehneh M
Rev Assoc Med Bras (1992); 2018 Oct; 64(10):942-951. PubMed ID: 30517243
[TBL] [Abstract][Full Text] [Related]
2. The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: a meta-analysis.
He Y; Xu X; Chen H; Wang J; Xiong W; Xu Y; Liu J
Gene; 2013 Jul; 523(2):199-204. PubMed ID: 23587910
[TBL] [Abstract][Full Text] [Related]
3. MLH1 and XRCC1 polymorphisms in Mexican patients with colorectal cancer.
Muñiz-Mendoza R; Ayala-Madrigal ML; Partida-Pérez M; Peregrina-Sandoval J; Leal-Ugarte E; Macías-Gómez N; Peralta-Leal V; Meza-Espinoza JP; Moreno-Ortiz JM; Ramírez-Ramírez R; Suárez-Villanueva S; Gutiérrez-Angulo M
Genet Mol Res; 2012 Aug; 11(3):2315-20. PubMed ID: 22843073
[TBL] [Abstract][Full Text] [Related]
4. [Association of genetic polymorphisms and haplotypes in hMLH1 and hMSH3 gene with the risk of papillary thyroid carcinoma].
Shi WP; Bian JC; Jiang F; Ni HX; Zhu QX; Tang HW; Shen Q; Wu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):390-5. PubMed ID: 18683134
[TBL] [Abstract][Full Text] [Related]
5. Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.
Wang T; Liu Y; Sima L; Shi L; Wang Z; Ni C; Zhang Z; Wang M
PLoS One; 2012; 7(11):e50449. PubMed ID: 23226285
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of human mutL homolog 1 and colorectal cancer risk: A meta-analysis.
Shi B; Chu J; Gao Q; Tian T
J Cancer Res Ther; 2018; 14(4):851-855. PubMed ID: 29970664
[TBL] [Abstract][Full Text] [Related]
7. [Study on genetic polymorphism of human mismatch repair gene hMLH1 and susceptibility of papillary thyroid carcinoma in Chinese Han people].
Shi WP; Bian JC; Jiang F; Ni HX; Zhu QX; Tang HW; Shen Q; Wu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Mar; 44(3):235-41. PubMed ID: 20450746
[TBL] [Abstract][Full Text] [Related]
8. A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer.
Nejda N; Iglesias D; Moreno Azcoita M; Medina Arana V; González-Aguilera JJ; Fernández-Peralta AM
Cancer Genet Cytogenet; 2009 Sep; 193(2):71-7. PubMed ID: 19665066
[TBL] [Abstract][Full Text] [Related]
9. MLH1-93G > A is a risk factor for MSI colorectal cancer.
Whiffin N; Broderick P; Lubbe SJ; Pittman AM; Penegar S; Chandler I; Houlston RS
Carcinogenesis; 2011 Aug; 32(8):1157-61. PubMed ID: 21565826
[TBL] [Abstract][Full Text] [Related]
10. Association Between the hOGG1 1245C>G (rs1052133) Polymorphism and Susceptibility to Colorectal Cancer: a Meta-analysis Based on 7010 Cases and 10,674 Controls.
Ghelmani Y; Asadian F; Antikchi MH; Dastgheib SA; Shaker SH; Jafari-Nedooshan J; Neamatzadeh H
J Gastrointest Cancer; 2021 Jun; 52(2):389-398. PubMed ID: 33025423
[TBL] [Abstract][Full Text] [Related]
11. -93G-->A polymorphism of hMLH1 and risk of primary lung cancer.
Park SH; Lee GY; Jeon HS; Lee SJ; Kim KM; Jang SS; Kim CH; Lee WK; Kam S; Park RW; Kim IS; Jung TH; Park JY
Int J Cancer; 2004 Nov; 112(4):678-82. PubMed ID: 15382050
[TBL] [Abstract][Full Text] [Related]
12. Association between MutL homolog 1 polymorphisms and the risk of colorectal cancer: a meta-analysis.
Chen H; Shen Z; Hu Y; Xiao Q; Bei D; Shen X; Ding K
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2147-58. PubMed ID: 25986311
[TBL] [Abstract][Full Text] [Related]
13. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Raptis S; Mrkonjic M; Green RC; Pethe VV; Monga N; Chan YM; Daftary D; Dicks E; Younghusband BH; Parfrey PS; Gallinger SS; McLaughlin JR; Knight JA; Bapat B
J Natl Cancer Inst; 2007 Mar; 99(6):463-74. PubMed ID: 17374836
[TBL] [Abstract][Full Text] [Related]
14. A promoter polymorphism in the hMLH1 gene (-93G/A) associated with sporadic colorectal cancer.
Zhang LL; Tang XJ; Wang XY; Zhu YW; Peng XB; Gong L
Oncol Lett; 2016 Nov; 12(5):4035-4040. PubMed ID: 27895767
[TBL] [Abstract][Full Text] [Related]
15. Common genetic variants (rs4779584 and rs10318) at 15q13.3 contributes to colorectal adenoma and colorectal cancer susceptibility: evidence based on 22 studies.
Tu L; Yan B; Peng Z
Mol Genet Genomics; 2015 Jun; 290(3):901-12. PubMed ID: 25475391
[TBL] [Abstract][Full Text] [Related]
16. Intronic and promoter polymorphisms of hMLH1/hMSH2 and colorectal cancer risk in Heilongjiang Province of China.
Li G; Hu F; Yuan F; Fan J; Yu Z; Wu Z; Zhao X; Li Y; Li S; Rong J; Cui B; Dong X; Yuan H; Zhao Y
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1393-404. PubMed ID: 25560462
[TBL] [Abstract][Full Text] [Related]
17. Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking.
Yu JH; Bigler J; Whitton J; Potter JD; Ulrich CM
Am J Gastroenterol; 2006 Jun; 101(6):1313-9. PubMed ID: 16771955
[TBL] [Abstract][Full Text] [Related]
18. Survivin and angiotensin-converting enzyme polymorphisms with risk of colorectal cancer: a systematic review and meta-analysis.
Zhou X; Lin C
World J Surg Oncol; 2015 Feb; 13():27. PubMed ID: 25889770
[TBL] [Abstract][Full Text] [Related]
19. Lack of associations between XPC polymorphisms and colorectal cancer: a meta-analysis.
Wang G; Sun H; Liu Z; Huang R; Chen Y; Tang Q; Yu L; Jiang Z; Wang X
J BUON; 2015; 20(3):770-4. PubMed ID: 26214629
[TBL] [Abstract][Full Text] [Related]
20. SMAD7 polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
Huang Y; Wu W; Nie M; Li C; Wang L
Oncotarget; 2016 Nov; 7(46):75561-75570. PubMed ID: 28070019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
